(Q36512827)

14 August 2017

Sixteen-year longitudinal changes in serum prostate-specific antigen levels: the olmsted county study (English)

1 reference

14 August 2017

Steven J Jacobsen

1

0 references

Jennifer L St Sauver

series ordinal

4

object named as

Jennifer L St Sauver

1 reference

14 August 2017

2

Debra J Jacobson

1 reference

14 August 2017

3

Michaela E McGree

1 reference

14 August 2017

6

Cynthia J Girman

1 reference

14 August 2017

7

Michael M Lieber

1 reference

14 August 2017

George G Klee

5

1 reference

PMC publication ID

3538390

14 August 2017

language of work or name

English

0 references

publication date

1 January 2012

1 reference

14 August 2017

1 reference

14 August 2017

87

1 reference

14 August 2017

1

1 reference

14 August 2017

34-40

1 reference

An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohort

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

The association between total prostate specific antigen concentration and prostate specific antigen velocity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

Dropout in a longitudinal, cohort study of urologic disease in community men.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

Establishing normal reference ranges for PSA change with age in a population-based study: The Krimpen study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

Relationship between initial prostate specific antigen level and subsequent prostate cancer detection in a longitudinal screening study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

Longitudinal evaluation of prostate-specific antigen levels in a case-control study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

Natural History of Changes in Prostate Specific Antigen in Early Stage Prostate Cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

Longitudinal data analysis for discrete and continuous outcomes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

Natural history of prostatism: risk factors for acute urinary retention

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

Prostate specific antigen assay standardization bias could affect clinical decision making.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

Prostate specific antigen velocity in men with total prostate specific antigen less than 4 ng/ml

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

Interchangeability of measurements of total and free prostate-specific antigen in serum with 5 frequently used assay combinations: an update.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

Impact of race and baseline PSA on longitudinal PSA.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

Longitudinal PSA changes in men with and without prostate cancer: assessment of prostate cancer risk.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

The natural history of prostatism: the effects of non-response bias.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

A population-based study of health care-seeking behavior for treatment of urinary symptoms. The Olmsted County Study of Urinary Symptoms and Health Status Among Men

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

The prevalence of prostatism: a population-based survey of urinary symptoms

21 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538390

Effect of finasteride on serum PSA concentration in men with benign prostatic hyperplasia. Results from the North American phase III clinical trial

21 October 2018

1 reference

12 December 2020

Comparability of the tandem-R andIMx assays for the measurement of serum prostate-specific antigen

1 reference

12 December 2020

Stability of serum prostate-specific antigen determination across laboratory, assay, and storage time

1 reference

12 December 2020

Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocity

1 reference

12 December 2020

PSA velocity and prostate cancer detection: the absence of evidence is not the evidence of absence

1 reference

12 December 2020

Comparison of Methods for Calculating Prostate Specific Antigen Velocity

1 reference

12 December 2020

1 reference

12 December 2020

Redesigned proficiency testing materials improve survey outcomes for prostate-specific antigen. A College of American Pathologists Ligand Assay Survey tool

1 reference

12 December 2020

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

1 reference

12 December 2020

10.1016/J.MAYOCP.2011.09.002

Identifiers

DOI

1 reference

14 August 2017

1 reference

PMC publication ID

3538390

14 August 2017

PubMed publication ID

22212966

1 reference

PMC publication ID

3538390